Kawasaki, Japan

Hayato Nagano

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hayato Nagano: Innovator in Antibody Affinity Compounds

Introduction

Hayato Nagano is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that interact with antibodies. His innovative work has led to the filing of a patent that showcases his expertise and creativity in this specialized area.

Latest Patents

Hayato Nagano holds a patent for a compound having an affinity substance to an antibody, a cleavable portion, and a reactive group, or a salt thereof. This patent is represented by the following formula: A-L-B—R. This invention is crucial for advancements in therapeutic applications and diagnostics, highlighting the importance of his work in the scientific community.

Career Highlights

Nagano is currently employed at Ajinomoto Co., Ltd., a leading company known for its contributions to food and biotechnology. His role at Ajinomoto allows him to further explore and develop innovative solutions in the field of biochemistry. His dedication to research and development has positioned him as a key figure in his area of expertise.

Collaborations

Hayato Nagano has collaborated with esteemed colleagues such as Kei Yamada and Yoshihiko Matsuda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research conducted at Ajinomoto.

Conclusion

In summary, Hayato Nagano is a distinguished inventor whose work on antibody affinity compounds has the potential to impact various applications in medicine and biotechnology. His contributions, along with his collaborations, continue to drive innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…